-+ 0.00%
-+ 0.00%
-+ 0.00%

Gene One Life Science Appeals KRX Delisting Decision

PUBT·11/19/2026 09:34:36
Listen to the news
Gene One Life Science Appeals KRX Delisting Decision
  • Gene One Life Science filed an appeal against delisting on Nov. 19, 2026.
  • An Oct. 29, 2026, listing eligibility review determined that the company met delisting criteria under Korea Exchange rules.
  • The exchange will convene its listing disclosure committee within 20 business days of receiving the appeal to review delisting.
  • A decision on delisting or granting an improvement period is due within three days of the committee's review.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261119800756), on November 19, 2026, and is solely responsible for the information contained therein.